Zeeshan Butt
Northwestern University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zeeshan Butt.
Liver Transplantation | 2010
Neehar D. Parikh; Daniela P. Ladner; Michael Abecassis; Zeeshan Butt
Living donor liver transplantation (LDLT) decreases the shortage of liver grafts for patients in need of a liver transplant, but it involves 2 patients: a recipient and a living donor. Despite the magnitude of the procedure for LDLT donors, only a few studies have investigated the effect of LDLT on the quality of life (QOL) of donors. We performed a systematic search of the MEDLINE database to identify peer‐reviewed articles assessing QOL in adults after LDLT donation. Nineteen studies describing 768 unique donors met our inclusion criteria for this review. The median number of donors enrolled in each study was 30 (range = 10‐143), and the median follow‐up period was 10.4 months (range = 3‐51.3 months). Before donation, donor QOL was significantly better than that in control adult populations across all measured QOL domains. Within the first 3 months after donation, the physical domains of QOL were significantly worse than the predonation levels, but they returned to baseline levels within 6 months for the majority of patients (80%‐93%). Mental domains of QOL remained unchanged throughout the donation process. Common donor concerns after LDLT included bloating, loss of muscle tone, poor body image, and fatigue. In conclusion, according to our review of the existing literature, most LDLT donors return to their baseline QOL within 6 months. However, there is a lack of long‐term data on donor QOL after LDLT, and few standardized assessments include measures of common patient concerns. Additional studies are necessary to develop a comprehensive risk profile for LDLT that includes a rigorous assessment of donor QOL. Liver Transpl 16:1352–1358, 2010.
Journal of Pain and Symptom Management | 2009
Jin Shei Lai; Zeeshan Butt; Lynne I. Wagner; Jerry J. Sweet; Jennifer L. Beaumont; Janette Vardy; Paul B. Jacobsen; Pamela J. Shapiro; Sheri R. Jacobs; David Cella
Decrements in cognitive function are common in cancer patients and other clinical populations. As direct neuropsychological testing is often not feasible or affordable, there is potential utility in screening for deficits that may warrant a more comprehensive neuropsychological assessment. Furthermore, some evidence suggests that perceived cognitive function (PCF) is independently associated with structural and functional changes on neuroimagery, and may precede more overt deficits. To appropriately measure PCF, one must understand its components and the underlying dimensional structure. The purpose of this study was to examine the dimensionality of PCF in people with cancer. The sample included 393 cancer patients from four clinical trials who completed a questionnaire consisting of the prioritized areas of concerns identified by patients and clinicians: self-reported mental acuity, concentration, memory, verbal fluency, and functional interference. Each area contained both negatively worded (i.e., deficit) and positively worded (i.e., capability) items. Data were analyzed by using Cronbachs alpha, item-total correlations, one-factor confirmatory factor analysis, and a bi-factor analysis model. Results indicated that perceived cognitive problem items are distinct from cognitive capability items, supporting a two-factor structure of PCF. Scoring of PCF based on these two factors should lead to improved assessment of PCF for people with cancer.
Journal of The American College of Surgeons | 2011
Dennis Leung; Amy K. Yetasook; JoAnn Carbray; Zeeshan Butt; Yumiko E. Hoeger; Woody Denham; Ermilo Barrera; Michael B. Ujiki
BACKGROUND Since the development of single-incision surgery, several retrospective studies have demonstrated its feasibility; however, randomized prospective trials are still lacking. We report a prospective randomized single-blinded trial with a cost analysis of single-incision (SI) to multi-incision (MI) laparoscopic cholecystectomy. STUDY DESIGN After obtaining IRB approval, patients with chronic cholecystitis, acute cholecystitis, or biliary dyskinesia were offered participation in this multihospital, multisurgeon trial. Consenting patients were computer randomized into either a transumbilical SI or standard MI group; patient data were then entered into a prospective database. RESULTS We report 79 patients that were prospectively enrolled and analyzed. Total hospital charges were found to be significantly different between SI and MI groups (MI
American Journal of Transplantation | 2012
Saeed Mohammad; L. Hormaza; Katie Neighbors; Pamela Boone; M. Tierney; R. K. Azzam; Zeeshan Butt; Estella M. Alonso
15,717 ±
Journal of Hepatology | 2015
Daniela P. Ladner; Mary Amanda Dew; Sarah Forney; Brenda W. Gillespie; Robert S. Brown; Robert M. Merion; Chris E. Freise; Paul H. Hayashi; Johnny C. Hong; April Ashworth; Carl L. Berg; James R. Burton; Abraham Shaked; Zeeshan Butt
14,231 vs SI
Journal of Hand Surgery (European Volume) | 2012
Sally E. Jensen; Zeeshan Butt; Alex Bill; Talia Baker; Michael Abecassis; Allen W. Heinemann; David Cella; Gregory A. Dumanian
17,817 ±
American Journal of Transplantation | 2013
Elisa J. Gordon; Zeeshan Butt; Sally E. Jensen; A. Lok-Ming Lehr; John E. Franklin; Yolanda T. Becker; L. A. Sherman; W. J. Chon; N. Beauvais; J. Hanneman; D. Penrod; Michael G. Ison; Michael Abecassis
5,358; p < 0.0001). Broken down further, the following subcharges were found to also be significant: operating room charges (MI
JAMA Surgery | 2014
Karl Y. Bilimoria; David Cella; Zeeshan Butt
4,445 ±
Health Psychology | 2013
Jill M. Cyranowski; Nicholas Zill; Rita K. Bode; Zeeshan Butt; Morgen A. R. Kelly; Paul A. Pilkonis; John M. Salsman; David Cella
1,078 vs SI
Oncologist | 2011
Jennifer L. Beaumont; Zeeshan Butt; Jeanfrancois Baladi; Robert J. Motzer; Tomas Haas; Norbert Hollaender; Andrea Kay; David Cella
5,358 ± 893; p < 0.0001); medical/surgical supplies (MI